Skin Cancer Resource Center
Featured Content
Treatment Considerations for Rare Skin Cancers
Dr. Christopher Miller, MD, Director of the Penn Dermatology Oncology Center, discusses rare skin cancers which are frequently misdiagnosed and have a high recurrence.
Second Opinion Boosts Melanoma Diagnostic Accuracy
Unlike other cancer diagnoses that rely on objective measures, melanoma is often diagnosed based on a pathologist’s subjective assessment of a skin biopsy. With such an approach, it’s no wonder skin cancer biopsies are linked with some of the most unreliable readings.
Cutting-Edge Technology in Use for Stage I & II Skin Cancers
Dr. Christopher Miller, MD, Director of the Penn Dermatology Oncology Center, discusses his group’s contributions and advancements in treating stage I and II melanomas that arise in special sites.
Loading